glp-1 and osteoarthritis Frontiers Beyond weight loss: GLP-1 emerges

Limited recent data exist on prescribing patterns and patient characteristics for GLP-1 RA medications, whether used as anti-diabetic medication (ADM) for patients with type 2 diabetes (T2D) and/or used as an anti-obesity medication ( for patients with overweight or obesity

Investigational medicinal product was stopped for 5 participants in the liraglutide arm due to adverse events (5/13)

10 Weight loss has been shown to improve factors that contribute to both the inflammatory and endogenous factors that contribute to acne

An important study published in the Annals of Clinical Endocrinology and Metabolism found that patients with Hashimoto thyroiditis have altered GLP-1 and GLP-2 serum levels compared to healthy controls

Alhadeff AL, Baird JP, Swick JC, Hayes MR, Grill HJ